A type 2 diabetes drug may stop thousands of obese people from needing gastric bypasses, scientists claim.
US researchers at the Mayo Clinic found liraglutide, which controls appetite, helped patients lose 12lbs over three months on average.
The prescription-only drug, which is self-injected, helps to slow down the stomach from emptying – making patients feel fuller for longer.
American experts believe the drug could steer fat adults onto the right path and avoid the need of expensive weight loss operations.